Mark Woodward

Professor Mark Woodward is a Visiting Professor at the School of Cardiovascular & Metabolic Health, University of Glasgow. His research focuses on cardiovascular disease prediction, biomarker development, and epidemiological risk modeling. He has contributed to national risk assessment tools like the updated Scottish ASSIGN score and led studies on biomarkers for heart failure and diabetes complications.

Key research themes include inflammatory markers in cardiovascular outcomes, coagulation factor analysis, and the interplay between cardiometabolic risk factors and kidney function decline. His work leverages large-scale cohort studies such as Generation Scotland and the ADVANCE trial, emphasizing translational research for clinical application.

Recent studies highlight proteomics-based approaches for disease prediction and the role of amino acids in diabetes complications. Collaborations span hematology, epidemiology, and digital health innovation, particularly in telemedicine applications for chronic heart failure management.

Woodward has published extensively in top journals like Circulation and Clinical Chemistry, with over 40 peer-reviewed articles since 2000. His research bridges basic science and public health, addressing critical gaps in cardiovascular risk stratification and precision medicine.